NCT05542342
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05542342
Title Sitravatinib and Tislelizumab in Patients With Metastatic Uveal Melanoma With Liver Metastases. (SITISVEAL)
Acronym SITISVEAL
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Grupo Español Multidisciplinar de Melanoma
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Universitario Virgen de la Macarena Seville Andalusia 41009 Spain Details
Institut Catala Oncologia (ICO) L´Hospitalet L'Hospitalet de Llobregat Barcelona 08908 Spain Details
Hospital Universitario la Paz Madrid Madrid 28046 Spain Details
Hospital General Universitario de Valencia Valencia Valencia 46014 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field